This federal contract award is for the procurement of the emergency oncology medication Belzutifan (WELIREG) by the U.S. Department of Veterans Affairs (VA) for the M'boro VA Pharmacy. The $19,761.11 firm fixed price contract was awarded to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., on May 26, 2022 under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which has a $3.1 billion ceiling value and runs through August 2024. This delivery order was placed without a set-aside designation, as Janssen Biotech is a large, for-profit pharmaceutical manufacturer. The contract supports the VA's Veterans Health Administration (VHA) in providing critical cancer treatment medications to veterans across the country through the agency's regional Veterans Integrated Service Networks (VISNs).
Generated 9/13/24, 10:34 AM